Clinical Trial Update: Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial evaluates circulating tumor DNA testing to predict and guide adjuvant treatment decisions for patients with Stage IIA colon cancer after surge…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Adenocarcinoma
• Colon Cancer

Snippet

Sponsor: NRG Oncology | Conditions: Colon Adenocarcinoma, Stage IIA Colon Cancer AJCC v8 | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-04-27